Accelus Announces First Procedure Integrating Remi Robotic Navigation System, LineSider Spinal System, and FlareHawk Expandable Interbody Fusion Device Technologies

Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the successful completion of the first surgery integrating its Remi™ Robotic Navigation, LineSider® Spinal System, and FlareHawk® Expandable Interbody Fusion Device systems in one procedure. The case was performed by board-certified and dual-fellowship-trained neurosurgeon Dr. Tien V. Le in March 2022 in Brandon, Florida.

“Accelus’ Remi Robotic Navigation System with LineSider pedicle screws, in tandem with its FlareHawk interbody fusion system, were ideal for performing this case, as the patient was experiencing instability and compression of the nerve roots following a previous decompression surgery that necessitated intervention,” said Dr. Le. “The use of all three novel technologies enabled a seamless, minimally invasive approach, which allowed for smaller incisions and a less pronounced interbody insertion profile, minimizing the risk of nerve injury.”

Dr. Le is a leader in providing minimally invasive surgical solutions and was selected by Dr. Kevin Foley, surgeon designer of the Remi Robotic Navigation System, to the prestigious post-graduate Spine Neurosurgery Fellowship at Semmes-Murphey Neurologic & Spine Institute. Certified for the use of robotic-assisted spine surgery since 2013, Dr. Le has recently incorporated the Remi system into his spine fusion procedures to help navigate the placement of pedicle screws in a more precise and accurate manner.

“Given its small size and compact setup when compared to incumbent spinal robotic technologies, Remi is well suited to advance the standard of care for robotic spinal navigation and will play a pivotal role in robotic-assisted spinal surgery in the years to come,” Dr. Le added. “Robotic-assisted navigation augments the well-established benefits of minimally invasive spinal surgery, reduces radiation exposure to the surgeon and everyone else in the operating room, and allows for the accurate placement of pedicle screws in otherwise difficult anatomy that may not be well visualized using conventional techniques.”

The Remi platform provides robotic-assisted placement of the LineSider Spinal System, a low-profile, minimally invasive pedicle screw system utilizing extended tab technology. Dr. Le also used FlareHawk in this procedure and has performed approximately 100 FlareHawk cases to date. FlareHawk, Accelus’ flagship product, features proprietary multidirectional expansion technology, designed to minimize neural retraction during implant insertion.

“Since our inception, Accelus has been focused on designing products that reconcile the desire of spine surgeons for a minimally invasive approach with the need for maximum clinical results,” said Chris Walsh, CEO and Co-Founder of Accelus. “Successful outcomes from procedures such as Dr. Le’s recent groundbreaking surgery validate our mission, and we look forward to expanding our scope to a variety of surgical approaches that can be performed across several clinical settings, including ASCs, in the future.”


Accelus is committed to accelerating minimally invasive spine surgery through its enabling technology with broad accessibility to previously underserved markets. Established in 2021 through the combination of Integrity Implants and Fusion Robotics, the company is focused on providing its proprietary Adaptive Geometry™ technology with pragmatic and economical navigation and robotic solutions with broad clinical use in spine surgery. Learn more at www.accelusinc.com.

SourceAccelus
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version